AR-12286 0.5% ophthalmic solution

DRUG2 trials

Sponsors

Aerie Pharmaceuticals

Conditions

GlaucomaOcular HypertensionOpen Angle Glaucoma

Phase 2

Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular Pressure

CompletedNCT01060579

Aerie PharmaceuticalsGlaucoma

Start: 2010-02-28End: 2010-08-31Updated: 2014-05-08

24-hour Efficacy of AR-12286

CompletedNCT01330979

Aerie PharmaceuticalsOcular Hypertension, Open Angle Glaucoma

Start: 2011-05-31End: 2012-08-31Updated: 2014-04-21